Judge Upholds Zyprexa Patent
In a major victory for Eli Lilly & Co., an Indiana federal judge has upheld the patent on the key ingredient on its $4.4 billion-a-year Zyprexa schizophrenia drug....To view the full article, register now.
Already a subscriber? Click here to view full article